Investor

BioAdvance

An evergreen investment fund backing early-stage life-science companies in the Mid-Atlantic

Write a review

Healthtech

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

TrustList summary

BioAdvance Capital is an evergreen fund that invests in early-stage life-science companies located in the Mid-Atlantic region of the United States, taking a long-term view on its investments. The firm says it continues to grow and invest while keeping its focus on that region, and describes its role as helping launch successful companies from within its portfolio. Companies in its portfolio have worked across areas including radiopharmaceuticals, physician retention research, tissue engineering and wearable respiratory monitoring, among others named on its site such as Immunome, Relmada Therapeutics and Ossianix. Its site also references board appointments at portfolio companies, including new director appointments at ImmunoGenesis and a new chairman and independent director at Latus Bio. BioAdvance Capital is based in Conshohocken, Pennsylvania.

Summary written by TrustList from the business's own published information, Sep 2026.

Gallery

2 images - click to enlarge

Categories & features

Healthtech

Rankings

BioAdvance is ranked on 1 TrustList ranking at #38.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. BioAdvance has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Investor · 1 ranking

#38of 92
Healthtech investors
Of the top 62 here, 17 also cover artificial intelligence and 13 also cover partners; 14 also work in New York City and 12 also work in London.
Behind Better Ventures, ahead of Breyer Capital.

As of 2026-11-01. Organic ranks only; sponsored placements are never ranks. How TrustList ranks